Diagnostic and therapeutic technology assessment. Radiofrequency catheter ablation of aberrant conducting pathways of the heart.
Radiofrequency catheter ablation has very quickly generated considerable enthusiasm among electrophysiologists because it offers a less invasive alternative to an open surgical procedure and potentially offers an alternative to lifelong drug therapy. Early literature on RF catheter ablation focused on the technical aspects of the procedure. In contrast, the literature of the past several years is dominated by very favorable reports of large series of patients and the experience of individual institutions. The larger series have focused on the treatment of accessory pathways as opposed to AV nodal reentry pathways. The opinions of the DATTA panelists parallel the literature. The panelists considered the technology to be established in terms of its safety and effectiveness as a curative treatment of accessory pathways, and promising in terms of its safety and between promising and established in terms of its effectiveness as a treatment of AV nodal reentrant tachycardias.
Vatz
J B
JB
Brown
E F
EF
D000574:American Medical Association; D017115:Catheter Ablation; D006801:Humans; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery*; D013614:Tachycardia, Paroxysmal / Q000601:surgery; D013617:Tachycardia, Supraventricular / Q000601:surgery; D013673:Technology Assessment, Biomedical; D014481:United States; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications